Literature DB >> 6840846

Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix.

R C Brunham, C C Kuo, L Cles, K K Holmes.   

Abstract

We studied 95 women with uncomplicated Chlamydia trachomatis cervical infection. Quantitative isolation of C. trachomatis was performed in HeLa 229 cells, and the results were correlated with serum immunoglobulin M and immunoglobulin G antibody to the organism. We found that quantitative cultures for C. trachomatis can provide a meaningful measurement by which to evaluate the effect of the acquired immune response. In particular, secretory immunoglobulin A antibody to C. trachomatis in cervical secretion demonstrated a striking and inverse correlation with recovery of the organism from the cervix. It is suggested that this component of the immune response may regulate shedding of the organism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840846      PMCID: PMC348123          DOI: 10.1128/iai.39.3.1491-1494.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Neutralization of Chlamydia trachomatis in cell culture.

Authors:  L V Howard
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

2.  The production of antisera that neutralize inclusion blennorrhoea virus.

Authors:  W A BLYTH; P REEVE; D M GRAHAM; J TAVERNE
Journal:  Br J Exp Pathol       Date:  1962-06

3.  The titration of trachoma and inclusion blennorrhoea viruses in cell cultures.

Authors:  G FURNESS; D M GRAHAM; P REEVE
Journal:  J Gen Microbiol       Date:  1960-12

4.  Peroxidase from human cervical mucus. The isolation and characterisation.

Authors:  J S Shindler; R E Childs; W G Bardsley
Journal:  Eur J Biochem       Date:  1976-06-01

5.  Chlamydia A in the female genital tract.

Authors:  A L Hilton; S J Richmond; J D Milne; F Hindley; S K Clarke
Journal:  Br J Vener Dis       Date:  1974-02

6.  Peroxidase-mediated antimicrobial activity of rat uterine fluid.

Authors:  S J Klebanoff; D C Smith
Journal:  Gynecol Invest       Date:  1970

7.  Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody.

Authors:  S P Wang; J T Grayston; E R Alexander; K K Holmes
Journal:  J Clin Microbiol       Date:  1975-03       Impact factor: 5.948

8.  Interaction of specific and innate factors of immunity: IgA enhances the antimicrobial effect of the lactoperoxidase system against Streptococcus mutans.

Authors:  J Tenovuo; Z Moldoveanu; J Mestecky; K M Pruitt; B M Rahemtulla
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

9.  Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans.

Authors:  R C Brunham; D H Martin; C C Kuo; S P Wang; C E Stevens; T Hubbard; K K Holmes
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

10.  Microtest procedure for isolation of Chlamydia trachomatis.

Authors:  B L Yoder; W E Stamm; C M Koester; E R Alexander
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948

View more
  87 in total

1.  Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?

Authors:  S Bas; C Scieux; T L Vischer
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  Accuracy of two enzyme immunoassays and cell culture in the detection of Chlamydia trachomatis in low and high risk populations in Senegal.

Authors:  E Van Dyck; N Samb; A D Sarr; L Van de Velden; J Moran; S Mboup; I Ndoye; J L Lamboray; A Meheus; P Piot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

3.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

4.  Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization.

Authors:  Z D Cui; D Tristram; L J LaScolea; T Kwiatkowski; S Kopti; P L Ogra
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

5.  Frequency of Chlamydia trachomatis-specific T cell interferon-γ and interleukin-17 responses in CD4-enriched peripheral blood mononuclear cells of sexually active adolescent females.

Authors:  Romina Barral; Ruchi Desai; Xiaojing Zheng; Lauren C Frazer; Gina S Sucato; Catherine L Haggerty; Catherine M O'Connell; Matthew A Zurenski; Toni Darville
Journal:  J Reprod Immunol       Date:  2014-02-01       Impact factor: 4.054

6.  Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.

Authors:  J U Igietseme; I M Uriri; S N Kumar; G A Ananaba; O O Ojior; I A Momodu; D H Candal; C M Black
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Comparison of plasmid- and chromosome-based polymerase chain reaction assays for detecting Chlamydia trachomatis nucleic acids.

Authors:  J B Mahony; K E Luinstra; J W Sellors; M A Chernesky
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis).

Authors:  D M Williams; J Schachter; M H Weiner; B Grubbs
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

10.  Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.

Authors:  T W Cotter; Q Meng; Z L Shen; Y X Zhang; H Su; H D Caldwell
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.